Detalles de la búsqueda
1.
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19.
Nat Immunol;
24(7): 1161-1172, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37322179
2.
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
N Engl J Med;
384(20): 1885-1898, 2021 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33725432
3.
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Lancet;
397(10269): 99-111, 2021 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33306989
4.
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Lancet;
397(10277): 881-891, 2021 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33617777
5.
Association of Group B Streptococcus (GBS) Serum Serotype-Specific Anticapsular Immunoglobulin G Concentration and Risk Reduction for Invasive GBS Disease in South African Infants: An Observational Birth-Cohort, Matched Case-Control Study.
Clin Infect Dis;
73(5): e1170-e1180, 2021 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33341870
6.
Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses.
Clin Infect Dis;
65(suppl_2): S125-S132, 2017 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29117322
7.
Longitudinal IgA and IgG Response, and ACE2 Binding Blockade, to Full-Length SARS-CoV-2 Spike Protein Variants in a Population of Black PLWH Vaccinated with ChAdOx1 nCoV-19.
Viruses;
15(2)2023 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36851662
8.
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial.
Lancet Infect Dis;
23(3): 295-306, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36273491
9.
Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005).
Vaccine;
41(23): 3486-3492, 2023 05 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37149443
10.
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial.
Lancet HIV;
8(9): e568-e580, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34416193
11.
Causes of stillbirths among women from South Africa: a prospective, observational study.
Lancet Glob Health;
7(4): e503-e512, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30879510
Resultados
1 -
11
de 11
1
Próxima >
>>